Suresh S. Ramalingam, MD

Suresh S. Ramalingam, MD

Candidate for AACR Nominating Committee
Executive Director, Winship Cancer Institute of Emory University
Associate Vice President for Cancer, Woodruff Health Sciences Center
Atlanta, Georgia

Research Interests

Lung cancer; drug development; EGFR inhibition; immune check point inhibition; mechanisms to increase high quality stem-like CD8 T cells; overcoming acquired resistance to targeted therapy; developing predictive biomarkers; clinical trials.

Current Affiliations

Executive director, Winship Cancer Institute; associate vice-president, Woodruff Health Sciences Center; professor of hematology and medical oncology, Roberto C. Goizueta Chair for Cancer Research, Emory University School of Medicine, Atlanta, Georgia.

Previous Positions

Deputy director (2016-2021) and director of lung cancer program (2007-2012), Winship Cancer Institute of Emory University; assistant dean for cancer research (2016-2021) and director of medical oncology (2009-2021), Emory University School of Medicine, Atlanta, Georgia; assistant professor of medicine (2003-2007) and instructor (2003), Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; clinical assistant professor (1998-2000), Department of Medicine, Wayne State University School of Medicine, Detroit, Michigan.

Education

MB, BS, Kilpauk Medical College, University of Madras, Madras, India (1992).

Postdoctoral Training

Postdoctoral fellow, University of Pittsburgh School of Medicine (2002), Pittsburgh, Pennsylvania; chief medical resident (1997) and residency training (1996), Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan.

Selected AACR Services, Honors, and Awards

Member, AACR Cancer Centers Alliance Subcommittee on Clinical Research, Clinical Trials, Regulatory Science and Policy (2023-present); member, AACR Asian/Asian American and Native Hawaiian/Pacific Islander Task Force (2024-2025); member, AACR Annual Meeting Clinical Trial Committee (2019-2021); member, AACR-Johnson & Johnson Lung Cancer Innovation Science Grants Scientific Review Committee (2017-2019).

Selected Non-AACR Services, Honors, and Awards

Member, National Cancer Advisory Board Working Group (2025-present); member, Emory Healthcare Systems Operations Group (2024-present); member, NCI Streamlining Clinical Trials Working Group (2022-2024); member, ASCO Career Development Committee (2022-2024); lead mentor, ASCO Leadership Development Program (2022-2024); member, Systems Integration Council, Emory Healthcare (2022-2023); chair, ASCO CancerLinQ Oncology Leadership Council (2021-2022); member, Scientific Program Committee, 20th World Conference on Lung Cancer, Barcelona, Spain; member, Woodruff Health Sciences Center Research Advisory Council (2020-present); member, Scientific Program Committee, 19th World Conference on Lung Cancer, Toronto, Canada (2019); meeting co-chair, IASLC Targeted Therapies of Lung Cancer Meeting (2017-2022); member, Scientific Program Committee, 7th Latin American Lung Cancer Conference, Panama (2016); member, Scientific Program Committee, 17th World Conference on Lung Cancer, Vienna, Austria (2016); member, Policy Committee, NCI Lung MAP Clinical Trials (2015-present).

Candidates for the AACR Nominating Committee